Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Investment Counsel's BMY Position: Q1 2021 in Review
Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 0.45% in Q1 2021, buying an estimated $6.22K and bringing the position to 22,157 shares worth $1.4M. The position accounts for 0.98% of the portfolio, ranked #29.
Investment Counsel first reported a position in BMY in Q4 2015 and has held it in 22 quarters since. The position peaked at $1.7M in Q3 2017. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Investment Counsel held 22,157 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2021.
- Investment Counsel bought 100 Bristol-Myers Squibb shares in Q1 2021, an estimated $6.22K.
- Bristol-Myers Squibb made up 0.98% of Investment Counsel's portfolio in Q1 2021, its #29 holding.
- Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 22 quarters since.
- Investment Counsel's Bristol-Myers Squibb position peaked at $1.7M in Q3 2017.
- 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.